Four lanes. One methodology.

Capital raises, M&A, and MSO/ASC syndication for healthcare and biotech companies. Current book includes a behavioral health seed-stage raise, a DFW physician-investor ASC syndicate, and a non-equity operating partner role with a healthcare holding company building its VC raise plan.

Five-year proformas, sum-of-parts theses, banker mapping, term structure. We build the materials, the model, and the narrative — then help structure the deal.

• VC raise plans, pitch decks, and investor data rooms (seed through Series B)
• Cap table modeling and dilution analysis
• Five-year proformas calibrated to raise scenarios
• Sum-of-parts theses for asset-based valuation
• Banker mapping and investor outreach strategy
• Term sheet structuring and term structure analysis
• M&A advisory: buy-side diligence, sell-side preparation, fairness analysis
• MSO and ASC syndication structuring for physician-investor partnerships
• Investor narrative and unit economics development
• Board-grade financial reporting and capital event communications

Three specialized engagement types span this lane and the Fractional CFO lane:

• ASC Development & Construction — feasibility through Medicare certification. 12 turnkey ASCs delivered, 200,000+ sq ft developed.
• MSO Services (Institutional) — formation, multi-state PC compliance, MSA architecture, payor contracting, accounting consolidation, PE platform rollups.
• Practice Services (MCS MSO) — direct-to-practice operating platform for Florida independent practices. Eleven services across revenue cycle, fractional CFO, payor contracting, credentialing, compliance, HR, IT, marketing, patient access, and staff development.
• Healthcare and biotech founders preparing for VC, growth equity, or strategic transactions
• Physician groups structuring MSO or multispecialty ASC partnerships
• Healthcare holding companies executing M&A or growth capital raises
• PE-backed platforms preparing for exit or add-on acquisitions
• Family offices and institutional investors needing transaction support
Current Book Includes

A non-equity Operating Partner role with a healthcare holding company building its VC raise plan, a seed-stage VC raise for a behavioral health platform currently in market, and a multispecialty ASC physician-investor syndicate in the Dallas-Fort Worth area.

Productized operator-grade CFO services for physician practices. We took a four-location pain management group from 65-day DSO to 42-day DSO and $3M+ in annual cash flow within six months. Built for practices that need cash-flow stabilization before they're ready for a capital event.

The Fixers is the productized MCS Advisory offering for physician practices, multispecialty surgery centers, behavioral health platforms, and biotech ventures that need cash-flow stabilization, financial discipline, and operational rigor before a capital event.

• Fractional CFO engagements with embedded financial leadership
• Fractional COO engagements for operational turnaround and scale-up
• DSO reduction and revenue cycle optimization (20–30% DSO improvement track record)
• Pro forma development for expansion financing and capital events
• FP&A, budgeting, and cash flow management
• Payor contracting and credentialing oversight
• Practice accreditation support: MEDICARE certification, AAAHC, ACHC, Joint Commission
• Board-grade financial reporting
• Strategic frameworks: EOS, SWOT, BCG, Business Canvas
• Capital event readiness assessments
• Brand repositioning and revenue growth strategies
• Mergers and acquisitions support: valuations through integration
• Leadership development and team dynamics

• ASC Development & Construction — operational launch of new ASCs through Medicare certification, accreditation, and first revenue.
• MSO Services (Institutional) — fractional MSO leadership, revenue cycle centralization, accounting consolidation across rolled-up practices.
• Practice Services (MCS MSO) — direct-to-practice operating platform for Florida independent practices. Eleven services across revenue cycle, fractional CFO, payor contracting, credentialing, compliance, HR, IT, marketing, patient access, and staff development.

Took a four-location pain management practice from 65-day DSO to 42-day DSO and $3M+ in annual cash flow improvement within six months. Practice became capital-event-ready and proceeded to growth financing.

• Independent physician practices ($2M–$100M revenue)
• Multispecialty Ambulatory Surgery Centers
• Multi-site group healthcare practices
• Behavioral health and biotech companies pre-capital-event
• Healthcare companies that need a CFO but cannot yet justify a full-time hire

Institutional-grade equity research for individual and family-office investors. DCF, rNPV, fundamental analysis, M&A reverse-engineering. The same rigor a Sanofi BD team would run on an acquisition target, applied to the positions you actually hold.

CatalystIQ is the MCS Advisory product line that brings this institutional methodology to individual investors and family offices through an AI-powered terminal. Two-tier freemium model. Public launch coming July 2026.

• DCF and rNPV modeling engines with biotech pipeline auto-fill
• Monte Carlo simulation (Box-Muller normal distribution) for tail-risk analysis
• AI Portfolio Builder with risk profile calibration
• S&P 500 Market Intelligence dashboard (sentiment, fear/greed, forward P/E, sector YTD, VIX)
• AI-generated Earnings Insight reports — quarterly S&P 500 updates exportable to PDF, Word, PowerPoint
• Catalyst Calendar — PDUFA dates, FDA decisions, earnings events
• Premarket and after-hours movers screener
• Comparable M&A transactions database
• AI Chat Assistant with full financial context

Sangamo Therapeutics positioning analysis vs. 12 biotech M&A transactions ($50B+ aggregate deal value), with rNPV capture rate methodology. Available on the Insights page.

Public launch coming July 2026. Free tier plus Pro tier ($14.99/month or $149/year). 7-day free trial of Pro.

For ventures, founders, and investors in defense-health, DHA-adjacent, and dual-use medical.

Career service: Ops Officer for JTF CAPMED NCR (the $1.5B DoD consolidation merging 3 teaching hospitals and 48 clinics; 439K TRICARE beneficiaries; 9,600 staff), and led the U.S. medical delegation at the 2003 Madrid coalition conference for OIF medical capabilities across 30 nations.

• Ops Officer, JTF CAPMED NCR — the $1.5B DoD healthcare consolidation that merged three teaching hospitals, realigned 48 clinics under Joint Task Force reporting to the Secretary of Defense, and supported 439,000 TRICARE beneficiaries and 9,600 staff
• U.S. medical delegation lead, 2003 Madrid allied conference — sourcing coalition medical capabilities for the Operation Iraqi Freedom coalition strategy with 30 partner nations
• Senior Military Advisor to the Iraqi Army during the OIF surge
• Strategic and tactical roles at the Office of the Secretary of Defense, Army Medical Command, ARNORTH/NORTHCOM, and 3rd Army

• Capital advisory and M&A for defense-tech medical and dual-use medical ventures
• Strategic advisory for behavioral health platforms serving veteran populations
• Investment analysis on defense-health public equities and platforms
• MSO and group practice structuring with VA and TRICARE network considerations
• Strategic positioning for ventures targeting DHA, VA Community Care, and military medical buyers

• Defense-tech medical and dual-use medical founders raising capital
• Behavioral health platforms with veteran or military-adjacent populations
• Investors and family offices in the defense-health space
• Healthcare holding companies with federal health exposure

This practice area represents one of MCS Advisory's four lanes. The majority of our active engagements operate in private-sector healthcare M&A, VC raises, group practice and ASC advisory, and investment analysis.